Difference between revisions of "Moreb J, et al. Cancer Gene Ther. (1996) cited as Ref 665 in DOI: 10.1038/s41392-020-0110-5 (Q9928)"
Jump to navigation
Jump to search
(Created claim: PubMed ID (P140): 8785707, #quickstatements; #temporary_batch_1590001671040) |
(Created claim: Fourth Author string (P152): Zucali JR, #quickstatements; #temporary_batch_1590155310798) |
||||||||||||||
| (5 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 1996
| ||||||||||||||
| Property / Publication Date: 1996 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Cancer Gene Ther. | ||||||||||||||
| Property / Published In Name String: Cancer Gene Ther. / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 3 | ||||||||||||||
| Property / Volume: 3 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide (English) | ||||||||||||||
| Property / title: Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 24-30 | ||||||||||||||
| Property / Page(s): 24-30 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Fourth Author string | |||||||||||||||
| + | Zucali JR | ||||||||||||||
| Property / Fourth Author string: Zucali JR / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 13:50, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Moreb J, et al. Cancer Gene Ther. (1996) cited as Ref 665 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Moreb J
0 references
Schweder M
0 references
Suresh A
0 references
1996
0 references
Cancer Gene Ther.
0 references
3
0 references
Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide (English)
0 references
24-30
0 references
Zucali JR
0 references
